Health Canada grants IVD approval to Devyser’s NGS-based chimerism test, the first of its kind in Canada
Devyser is proud to announce that One Lambda Devyser Chimerism and Advyser Chimerism have been...
Thank you for requesting one of our whitepapers.
Devyser strengthens U.S. market presence with CMS pricing for PrenatalDetect RHD test
Devyser today announced that the Centers for Medicare & Medicaid Services (CMS) has issued its...
Devyser advances U.S. clinical strategy with first patient enrolled in Devyser Accept cfDNA study
Devyser today announced the enrollment of the first patient in its Devyser Accept cfDNA clinical...
Devyser CFTR achieves IVDR compliance, strengthening clinical confidence in cystic fibrosis diagnostics
Devyser, a pioneer in advanced genetic testing solutions, is pleased to announce that its...